Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

USNA

USANA HEALTH SCIENCES INC

$14.82Sep 28, 2026

AI confidence 47% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

USANA HEALTH SCIENCES INC shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +4% YoY in Q3 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +4% YoY in Q3 FY2026

Pipeline evidence · 0d ago

USNA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on USNA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q3 2026

Full USNA earnings analysis

Reported figures for USANA HEALTH SCIENCES INC — research only, not investment advice.

Revenue YoY
+4.5%

Latest Intelligence

Updated

What happened recently for USANA HEALTH SCIENCES INC (USNA) — events, not interpretation.

Event
Reported Q3 2026 revenue +5% YoY.
Also
Last session September 28, 2026 at $14.82.
Source
Q3 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

USANA HEALTH SCIENCES INC (USNA)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for USANA HEALTH SCIENCES INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:
$273.82M
Revenue:
$250.22M

USNA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow USANA HEALTH SCIENCES INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.